| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.095 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.13 | 0.01 |